About Arylamine N-acetyltransferase 2
Arylamine N-acetyltransferase 2 (NAT2) is a protein
from Homo sapiens identified by UniProt accession
P11245, 290 residues long.
MolForge cross-references it against 0 known binders and
221 disease associations.
Target properties
| Protein name | Arylamine N-acetyltransferase 2 |
| UniProt accession | P11245 |
| Gene | NAT2 |
| Organism | Homo sapiens |
| Length | 290 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (221)
Diseases linked to this target (Open Targets).
- triglyceride measurement · score 0.47
- total cholesterol measurement · score 0.46
- urinary metabolite measurement · score 0.44
- serum metabolite measurement · score 0.42
- blood metabolite measurement · score 0.41
- mean corpuscular hemoglobin concentration · score 0.41
- low density lipoprotein cholesterol measurement · score 0.41
- serum albumin measurement · score 0.40
- coronary artery disease · score 0.39
- urinary bladder carcinoma · score 0.39
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-P11245-F1 | alphafold | PREDICTED | 96.46 | — |
Amino-acid sequence (290 residues)
MDIEAYFERI GYKNSRNKLD LETLTDILEH QIRAVPFENL NMHCGQAMEL GLEAIFDHIV RRNRGGWCLQ VNQLLYWALT TIGFQTTMLG GYFYIPPVNK YSTGMVHLLL QVTIDGRNYI VDAGSGSSSQ MWQPLELISG KDQPQVPCIF CLTEERGIWY LDQIRREQYI TNKEFLNSHL LPKKKHQKIY LFTLEPRTIE DFESMNTYLQ TSPTSSFITT SFCSLQTPEG VYCLVGFILT YRKFNYKDNT DLVEFKTLTE EEVEEVLRNI FKISLGRNLV PKPGDGSLTI
Explore Arylamine N-acetyltransferase 2 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets